Primary versus interval debulking surgery in advanced ovarian cancer: results from a systematic single-center analysis.

Summary: For women with advanced ovarian cancer, doctors often face a difficult choice: operate immediately to remove the tumor (Primary Surgery) or start with chemotherapy to shrink the cancer before operating (Interval Surgery). This study looked at 372 patients to see which approach worked better.

The researchers found that while doing chemotherapy first made the surgery easier and more likely to remove all visible cancer, it didn't lead to better long-term results. In fact, patients who had surgery immediately—before chemotherapy—lived significantly longer and went more time without the cancer returning. The study suggests that operating first is the better option for survival, provided the surgeon can remove the tumor successfully.